New York, New Jersey Clinical Trials

A listing of New York, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 416 clinical trials
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840040
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +135 other locations
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

deficiency
myozyme
glycogen storage disease type ii
replacement therapy
gaa gene
Investigational Site Number 840040
 (3.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations
Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The primary …

fabry's disease
alpha-galactosidase
deficiency
fabrazyme
agalsidase beta
Investigational Site Number 840040
 (3.3 away) Contact site
  • 0 views
  • 05 Aug, 2024
  • +136 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

muscle rigidity
methyldopa
parkinson's disease
bradykinesia
modafinil
NYU Langone Health
 (3.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
Antigen Presentation and Lymphocyte Response in Parkinson's Disease  

The way the immune system responds to certain PD-related proteins in PD donors compared to the way it responds in persons without or fewer PD related proteins is not well studied and this study aims to analyze the autoimmune response in each group. The study involves a one time visit …

muscle rigidity
parkinson's disease
bradykinesia
tremor
resting tremor
Columbia University Medical Center
 (5.1 away)
  • 1784 views
  • 19 Feb, 2024
  • +2 other locations
Natural History Study of MNGIE

Non-interventional, prospective, multicenter, natural history study of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Columbia University
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +4 other locations
DISSECT-N Post Market Data Collection Registry

DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.

Northwell Health Lenox Hill Hospital
 (3.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Observing People With Desmoid-Type Fibromatosis

The purpose of this study is to closely observe people with desmoid-type fibromatosis over 1 months.

biospecimen collection
ct with intravenous contrast
fibromatosis
aggressive fibromatosis
Memorial Sloan Kettering Cancer Center
 (3.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Skeletal Fragility in Type 1 Diabetes: Glycemic Control and Bone Strength

The purpose of this research study is to find out how bones are affected in children and adolescents with type 1 diabetes (T1D) as compared to children and adolescents without type 1 diabetes.

autoimmune disease
insulin
type 1 diabetes mellitus
Columbia University Medical Center-Harkness Pavillion
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
An Observational Study on Sarilumab-exposed Pregnancies

Primary Objective: To evaluate the relative risk of major structural birth defects, specifically a pattern of anomalies, in sarilumab-exposed pregnancies compared to disease-matched unexposed pregnancies. Secondary Objective: To evaluate the risk for sarilumab-exposure relative to the group of healthy pregnant women, and the effect of exposure on other adverse pregnancy …

United States
 (5.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations